Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XL784 in albuminuria due to diabetic nephropathy
NCT00312780Phase 2Completed
- Sponsor
- Symphony Evolution
- Start
- Mar 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of XL784 in diabetic nephropathy (DN), sponsored by Symphony Evolution. Started Mar 2006; status: completed.
02
Drugs
XL784
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00312780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312780.